Investor Presentaiton

22 Key Takeaways Significant market opportunity in non-incisional glaucoma therapy Initial penetration demonstrates market demand exists Strong publication proofs and KOLs demonstrate efficacy and safety Proven sales process to focus on adoption and usage to drive growth Achieve financial returns through high margin disposables growth IRIDEX

View entire presentation